Top 5 Pharmaceutical Companies With Highest R&D Spending

In this article we are going to list the Top 5 Pharmaceutical Companies With Highest R&D Spending. For a detailed coverage of this topic and a more comprehensive list please head on over to the Top 15 Pharmaceutical Companies With Highest R&D Spending.

At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage. Keeping this in mind let’s take a look at the top 5 companies with the highest R&D spending:

5. Bristol Myer Squibb (NYSE:BMY)

Total R&D spend by the company in 2019 (in millions of dollars): 6,148

Total R&D spend by the company in 2019 (as a percentage of net sales): 23.5%

We have plenty of American companies in our list, and Bristol Myers Squibb is no exception, with more than $42 billion in sales in 2020. It is also currently the subject of a $1 billion lawsuit for its part in a role where the US government infected hundreds of Guatemalans with syphilis.

adriaticfoto/Shutterstock.com